Affiliations: [a] Master in Biosafety in Plant Biotechnology, UNIDO-UNIVPM program, Via Cesare Battisti 4, 34125 Trieste, Italy. e-mail: marianela.araya@gmail.com
| [b] Dipartimento di Scienze Ambientali e delle Produzioni Vegetali, Marche Polytechnic University, Via Brecce Bianche, 60100 Ancona, Italy | [c] Technology Unit UNIDO, UNIDO, PTC/PEM, Wagramerstrasse 5, P.O. Box 400, 1400 Vienna, Austria
Abstract: Tomatoes are a very important part of the Mediterranean diet. The possibility of a much healthier tomato option represents a great opportunity for the population to enhance their daily diet. Folate is an important bioactive compound for human health and increasing folate content in tomatoes can contribute to reduce some of the problems associated with this deficiency. In this review, the new option of a biofortified tomato produced by the use of DNA recombinant technology will be discussed in terms of food safety of the new genetically modified product. The possibility to increase folate content has been recently demonstrated through two modifications: the first was based on the development of a synthetic form of engineered GTP cyclohydrolase I (GCHI) (based on mammalian synthesis), which was introduced in the plants to prevent the retroinhibition of the GCHI (folate precursor) in plants; the second was based on the pteridine-overproduction trait expressing the aminodeoxychorismate synthase (AtADCS) from Arabidopsis thaliana. Genetically modified tomatoes, able to accumulate an average of 25-fold more folate than controls, were produced. These fruits could provide the complete adult daily requirement in less than one standard serving. The modification also resulted in a 20 times higher accumulation of pteridines and PABA as compared with the wild-type control. The possible risks and benefits derived from the GM modification of the tomato, and the safety of the final product for consumers will be discussed.
